74 related articles for article (PubMed ID: 7777720)
1. [Essential thrombocythemia].
Torre López E
Rev Invest Clin; 1995; 47(1):83-4. PubMed ID: 7777720
[No Abstract] [Full Text] [Related]
2. Essential thrombocythemia: a retrospective study on the clinical course of 100 patients.
Chistolini A; Mazzucconi MG; Ferrari A; la Verde G; Ferrazza G; Dragoni F; Vitale A; Arcieri R; Mandelli F
Haematologica; 1990; 75(6):537-40. PubMed ID: 2098295
[TBL] [Abstract][Full Text] [Related]
3. Busulfan versus hydroxyurea in the treatment of polycythemia vera (PV) and essential thrombocythemia (ET).
Brodsky I
Am J Clin Oncol; 1998 Feb; 21(1):105-6. PubMed ID: 9499248
[No Abstract] [Full Text] [Related]
4. Essential thrombocythemia: a relative benign long-term course.
Meisel S; Shpilberg O; Ramot B; Ben-Bassat I
Isr J Med Sci; 1993 Apr; 29(4):190-4. PubMed ID: 8491569
[TBL] [Abstract][Full Text] [Related]
5. The management of elderly patients with myeloproliferative disorders.
Tura S
Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
[No Abstract] [Full Text] [Related]
6. Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
Barbui T; Finazzi G
Curr Hematol Rep; 2003 May; 2(3):248-56. PubMed ID: 12901347
[TBL] [Abstract][Full Text] [Related]
7. New consensus: a unified definition of clinical resistance and/or intolerance to hydroxyurea in essential thrombocythaemia.
Barosi G
Eur J Haematol Suppl; 2007 Oct; (68):24-6. PubMed ID: 17727562
[No Abstract] [Full Text] [Related]
8. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
9. Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea.
Renso R; Aroldi A; Pioltelli P; Gambacorti-Passerini C; Elli EM
Blood Cancer J; 2018 Jun; 8(6):56. PubMed ID: 29891835
[No Abstract] [Full Text] [Related]
10. [Long-term treatment of thrombocytosis and thrombocythemia].
Linker H; Lindner HJ; Reuter H; Gross R
Med Welt; 1980 Apr; 31(14):509-12. PubMed ID: 7189572
[No Abstract] [Full Text] [Related]
11. [Essential thrombocythemia. Apropos of 3 cases].
Sanz Marca A; Rico Pérez MT; Aboín Massieu FJ; Rebollar Mesa JL
Rev Clin Esp; 1983 Mar; 168(5):347-50. PubMed ID: 6683423
[No Abstract] [Full Text] [Related]
12. Essential thrombocythemia in a child: diagnostic and therapeutic dilemma.
Asghar R; Behzad E; Mohammad GA
Saudi Med J; 2005 Nov; 26(11):1806-8. PubMed ID: 16311671
[TBL] [Abstract][Full Text] [Related]
13. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
[TBL] [Abstract][Full Text] [Related]
14. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
[No Abstract] [Full Text] [Related]
15. Essential thrombocythemia and acute leukemia.
Ferrari D; Ticozzelli G; De Vizzi M; Corigliano P; De Vizzi G
Haematologica; 1993; 78(6):401-2. PubMed ID: 8175035
[TBL] [Abstract][Full Text] [Related]
16. [Clinical case. Primary thrombocythemia].
Pozzato G; Terpin MM; Rinaldi C; Frezza M
G Clin Med; 1987 Feb; 68(2):121-3. PubMed ID: 3609602
[No Abstract] [Full Text] [Related]
17. [Some questions on the problem of thrombocythemia].
Frinovskaia IV
Probl Gematol Pereliv Krovi; 1968 Nov; 13(11):7-13. PubMed ID: 5753808
[No Abstract] [Full Text] [Related]
18. Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.
Shvidel L; Sigler E; Haran M; Klepfish A; Duek A; Berrebi A; Shtalrid M
Leukemia; 2007 Sep; 21(9):2071-2. PubMed ID: 17611572
[No Abstract] [Full Text] [Related]
19. Busulfan in early pregnancy.
Williams DW
Obstet Gynecol; 1966 May; 27(5):738-40. PubMed ID: 5220059
[No Abstract] [Full Text] [Related]
20. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.
Johansson P; Ricksten A; Wasslavik C; Johansson B; Andréasson B
Haematologica; 2004 Oct; 89(10):1264-6. PubMed ID: 15477215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
